uMed builds consented patient Cohorts that accelerate research and generate insights that improve outcomes for patients.

By leveraging uMed’s ACCESS platform which is embedded across a global network of healthcare institutions, researchers can rapidly access and engage with patients to generate insights derived from the decentralised collection of electronic health records, clinical outcomes, patient-reported data and biosamples. The ACCESS platform addresses critical evidence gaps needed to accelerate the delivery of new medicines and innovations to patients.